跳至主要内容

Comparison of E. coli and Insect Baculovirus Expression Systems

 

Principle of Escherichia coli Expression System

The Escherichia coli expression system is an expression system that efficiently expresses genes encoding protective antigens of pathogenic microorganisms in Escherichia coli through DNA recombination technology. It is currently the most commonly used system for recombinant protein expression. The E. coli expression system has been studied earlier and has many advantages such as clear background, simple operation, and high expression. The expression level is significantly higher than that of mammalian expression systems, but it also has corresponding shortcomings. For example, the E. coli system cannot secrete the expressed protein outside the cell, the ability to form disulfide bonds is limited, and complex modifications of protein expression (such as Glycosylation, etc.).

Principle of Baculovirus Expression System

Insect baculovirus expression vector system is a recombinant protein production system that uses recombinant insect baculovirus carrying foreign target genes as a vector for expression and production in insects or insect cultured cells.

Since the cycle required by this system is much shorter than that of animal or plant systems, individual insects or their cultured cells can be used for large-scale expression production, and the production of recombinant protein is high. The post-translational processing of protein is better than that of bacterial and yeast production systems. Because the insect baculovirus has a restricted host range, it only infects insects of specific species and their cells, and has no ability to infect humans and animals and other vertebrates. Therefore, it is safer than mammals and their cultured cell production systems. Advantages and become one of the most effective eukaryotic expression systems.

E. coli and Insect Baculovirus Expression Systems
E. coli and Insect Baculovirus Expression Systems

Advantages and Disadvantages of Each Expression System

Escherichia coli expression system

AdvantagesDisadvantagesTechnical difficulties
The operation is simple, the cycle is short, the income is large, and the expression product is stable.Easy to form inclusion bodies;
The protein lacks post-translational modification;
How to realize the expression of a large number of soluble proteins;
How to realize glycosylation modification of protein.

Baculovirus Expression System

AdvantagesDisadvantagesTechnical difficulties
Carry out post-translational glycosylation modification of the protein.High cost, low protein expression, difficult to form seed batchesIncrease protein expression and reduce production costs.
Improve inter-batch stability.

Medicilon’s Baculovirus-insect Cell Expression Services Platform

Medicilon researchers establish a well-developed baculovirus-insect cell expression services platform. We provide the expression and purification services on preparation of recombinant baculovirus and recombinant protein. We have a good track record in producing kinase and recombinant protein complexes.

Service:

  • Generation of recombinant Bacmid DNA

  • Preparation of recombinant baculovirus

  • Titration of baculovirus

  • Protein expression verification and optimization

  • Small scale expression and purification of recombinant protein in insect cell

  • Scale up expression and purification of recombinant protein in insect cell

Related Articles:

Baculovirus Expression Vector System

Baculovirus Expression System

Introduction of Bac-to-Bac System

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...